Therefore, a redox-sensitive nanoplatform co-delivering GEM and miR-159c was developed, which downregulates HIF-1α and genes responsible for glucose uptake and cancer cell metabolism, thereby significantly inhibiting orthotopic desmoplastic pancreatic cancer growth in NSG mice. This evidence concerns the gene HIF1A and familial pancreatic carcinoma.